CX3CR1 and Stroke: These findings indicated that our established classic 60‐min MCAO/reperfusion model suffered from significantly impaired cognitive and sensorimotor function in the chronic phase, but the CX3CR1 gene deletion could improve those functions in post‐stroke mice.